Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jia

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Folia Biologica|February 4, 2014
Protective effect of the nitric oxide pathway in L-citrulline renal ischaemia-reperfusion injury in ratsX Fu, S Li, G Jia, et al.
Magma (New York, N.Y.)|June 29, 2004
Benign prostate hyperplasia: evaluation of treatment response with DCE MRIJ T Heverhagen, H von Tengg-Kobligk, K T Baudendistel, et al.
Virology Journal|July 24, 2013
MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cellsJhy-Ming Li, Kuo-Chin Kao, Li-Fu Li, et al.
Poultry Science|August 24, 2021
Effect of supplementing hydroxy selenomethionine on meat quality of yellow feather broilerJ Y Tang, Z He, Y G Liu, et al.
Current Medical Research and Opinion|March 11, 2008
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertensionS Oparil, N Abate, E Chen, et al.
Molecular Therapy Oncolytics|March 4, 2020
MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Molecular Therapy Oncolytics|February 12, 2021
Erratum: MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Journal of Viral Hepatitis|March 6, 2013
Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosisZ Han, Y Shi, J Zhu, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|June 9, 2017
[Analysis of related factors for primary hepatic carcinoma caused by chronic hepatitis B and hepatitis C]L Nie, X C Wang, J Q Niu, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 6, 2017
[Effects on human peripheral erythrocytes of long-term occupational contact with chromate]G P Hu, L Zhao, J X Liu, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Folia Biologica|February 4, 2014
Protective effect of the nitric oxide pathway in L-citrulline renal ischaemia-reperfusion injury in ratsX Fu, S Li, G Jia, et al.
Magma (New York, N.Y.)|June 29, 2004
Benign prostate hyperplasia: evaluation of treatment response with DCE MRIJ T Heverhagen, H von Tengg-Kobligk, K T Baudendistel, et al.
Virology Journal|July 24, 2013
MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cellsJhy-Ming Li, Kuo-Chin Kao, Li-Fu Li, et al.
Poultry Science|August 24, 2021
Effect of supplementing hydroxy selenomethionine on meat quality of yellow feather broilerJ Y Tang, Z He, Y G Liu, et al.
Current Medical Research and Opinion|March 11, 2008
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertensionS Oparil, N Abate, E Chen, et al.
Molecular Therapy Oncolytics|March 4, 2020
MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Molecular Therapy Oncolytics|February 12, 2021
Erratum: MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Journal of Viral Hepatitis|March 6, 2013
Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosisZ Han, Y Shi, J Zhu, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|June 9, 2017
[Analysis of related factors for primary hepatic carcinoma caused by chronic hepatitis B and hepatitis C]L Nie, X C Wang, J Q Niu, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 6, 2017
[Effects on human peripheral erythrocytes of long-term occupational contact with chromate]G P Hu, L Zhao, J X Liu, et al.
Pageof 16